.jpeg)
Fujifilm India has launched a digital radiology X-ray centre in the Community Health Centre (CHC) in Dholera, Gujarat
Johnson & Johnson today reported the results of new Phase 3 data for seltorexant, a novel selective orexin-2 receptor antagonist, as an add-on treatment for adults and elderly patients with major depressive disorder (MDD) and insomnia symptoms...
Agilus Diagnostics, the flagship provider of diagnostic services in India, is a wholly-owned subsidiary of Fortis Healthcare Ltd., and has made the announcement of the introduction of its AgilusEDGE Comprehensive Genomic Profile
Indoco Remedies Limited has announced that the US FDA inspected its Active Pharmaceutical Ingredients (API) manufacturing facility at Patalganga, Navi Mumbai and has concluded with zero Form 483 observations. This is evidence of Indoco'...
.jpeg)
Datavant, the healthcare data collaboration network, has declared its strategic collaboration with Indegene to improve the effectiveness of recruitment in complicated studies.
In an interaction with Thiruamuthan, Correspondent, India Pharma Outlook, Anjali Ajaikumar, Director, Milann Fertility & Birthing Hospital, discusses the rising infertility challenge, evolving fertility treatments, and innovations shaping personalize
Eli Lilly and Company announced promising topline findings from its ACHIEVE-3 Phase 3 study, revealing that their investigational GLP-1 receptor agonist, orforglipron, which is administered orally once a day, was associated with better results...
Sai Life Sciences, a contract research, development, and manufacturing organization (CRDMO) focused on innovative medicines, announced Unit VI inauguration in Bidar, India, to manufacture veterinary active pharmaceutical...
Biocon Biologics Ltd. has received FDA approval for its denosumab biosimilars, Bosaya and Aukelso, marking a major milestone in expanding affordable biologic therapies in the U.S.
AstraZeneca has announced today landmark data from the Phase III FLAURA2 trial, demonstrating that its targeted therapy, Tagrisso (osimertinib), plus pemetrexed and platinum-based chemotherapy, achieved the longest overall survival reported in any...
.jpg)
.jpg)
, CDSCO.jpg)